We are live on
!
Find out more
Axa Portfolio holdings
AUM
$256M
1-Year Est. Return
25.01%
This Fund
S&P 500
This Quarter
Est. Return
-5.85%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$35.2B
AUM Growth
-$3.94B
(-10%)
Cap. Flow
-$1.12B
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
20.4%
Holding
1,273
New
111
Increased
414
Reduced
514
Closed
94
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$63.8M |
| 2 |
Align Technology
ALGN
|
+$61.4M |
| 3 |
Stellantis
STLA
|
+$54.4M |
| 4 |
UBS Group
UBS
|
+$49.7M |
| 5 |
Republic Services
RSG
|
+$44M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ferrari
RACE
|
+$73.1M |
| 2 |
IPG Photonics
IPGP
|
+$62.1M |
| 3 |
Adobe
ADBE
|
+$61.1M |
| 4 |
UnitedHealth
UNH
|
+$56.3M |
| 5 |
Apple
AAPL
|
+$54.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.78% |
| 2 | Healthcare | 17.08% |
| 3 | Financials | 11.22% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Industrials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Intercontinental Exchange
ICE
$87.2B
| $112M | 0.32% |
846,147
+76,268
| +10% | +$9.85M |
|
77
Elevance Health
ELV
$81.5B
| $112M | 0.32% |
227,321
-5,148
| -2% | -$2.35M |
|
78
Cisco
CSCO
$443B
| $109M | 0.31% |
1,958,874
-144,487
| -7% | -$8.18M |
|
79
Microchip Technology
MCHP
$38.8B
| $109M | 0.31% |
1,451,810
+22,110
| +2% | +$1.66M |
|
80
Walmart Inc
WMT
$909B
| $108M | 0.31% |
2,183,712
+136,419
| +7% | +$6.4M |
|
81
TJX Companies
TJX
$179B
| $108M | 0.31% |
1,782,766
+167,828
| +10% | +$11.2M |
|
82
Automatic Data Processing
ADP
$109B
| $106M | 0.3% |
465,401
-31,475
| -6% | -$6.74M |
|
83
PayPal
PYPL
$50.3B
| $105M | 0.3% |
903,918
-73,421
| -8% | -$9.77M |
|
84
NXP Semiconductors
NXPI
$60.8B
| $104M | 0.3% |
564,261
-9,421
| -2% | -$1.86M |
|
85
Moody's
MCO
$83.7B
| $101M | 0.29% |
298,020
-29,911
| -9% | -$10.1M |
|
86
Deere & Co
DE
$165B
| $99.5M | 0.28% |
239,439
+23,455
| +11% | +$8.99M |
|
87
Cognex
CGNX
$9.62B
| $97.9M | 0.28% |
1,268,759
-11,080
| -0.9% | -$759K |
|
88
JPMorgan Chase
JPM
$916B
| $97.9M | 0.28% |
717,915
+51,023
| +8% | +$7.53M |
|
89
CME Group
CME
$95.4B
| $96.2M | 0.27% |
404,573
+73,474
| +22% | +$17.3M |
|
90
Regeneron Pharmaceuticals
REGN
$72.9B
| $94M | 0.27% |
134,641
-36,434
| -21% | -$23.1M |
|
91
Verisk Analytics
VRSK
$27.9B
| $93.9M | 0.27% |
437,474
-58,814
| -12% | -$11.6M |
|
92
Chevron
CVX
$382B
| $93.2M | 0.27% |
572,628
+155,186
| +37% | +$22.3M |
|
93
Wolfspeed
WOLF
$1.04B
| $92.5M | 0.26% |
812,542
+175,156
| +27% | +$17.6M |
|
94
Intel
INTC
$413B
| $91.6M | 0.26% |
1,848,727
-512,626
| -22% | -$25.4M |
|
95
CONMED
CNMD
$1.3B
| $91.6M | 0.26% |
616,591
-9,916
| -2% | -$1.38M |
|
96
Boston Scientific
BSX
$68.4B
| $90.8M | 0.26% |
2,049,167
+306,950
| +18% | +$13.3M |
|
97
United Parcel Service
UPS
$88.9B
| $86.8M | 0.25% |
404,862
+120,581
| +42% | +$25.6M |
|
98
Sherwin-Williams
SHW
$84.8B
| $86.6M | 0.25% |
346,799
+11,345
| +3% | +$3.13M |
|
99
Amgen
AMGN
$209B
| $84.5M | 0.24% |
349,591
-78,467
| -18% | -$18M |
|
|
ATVI
100
DELISTED
Activision Blizzard
ATVI
| $82.3M | 0.23% |
1,027,217
-577,241
| -36% | -$45M |
|
Similar funds
PHAM
HFRG
EBWM
GCCM
CIA
KAM
ACM
CCA
Axa's Q1 2022 Portfolio in Review
As of Q1 2022, Axa held 1,273 positions worth $35.2B, down 10% from $39.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Axa withdrew a net $1.12B in Q1 2022, closing 94 positions and reducing 514 holdings. Its most notable exit was Zai Lab, an estimated $21.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Axa opened a new position in Freshpet worth $30.3M.
- Axa's largest Q1 2022 buy was Freshpet: 294,939 shares worth $30.3M.
- Axa added most to Pfizer in Q1 2022, an estimated $63.8M increase.
- Axa's biggest Q1 2022 reduction was Ferrari, cutting an estimated $73.1M.
- Axa fully exited Zai Lab in Q1 2022, selling an estimated $21.3M.
- Axa's ten largest holdings make up 20% of its $35.2B portfolio in Q1 2022.
- Axa opened 111 new positions and closed 94 in Q1 2022.
- Axa's portfolio value fell 10% quarter-over-quarter to $35.2B.
Based on Axa's 13F filing for Q1 2022, filed 13 May 2022.